Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
PaperCitations, authors & open-access status
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,372 citations, 2017 year and bronze oa status.
1,372
Citations
2017
Year
bronze
OA Status